Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: The B-1 malignancy, CLL has been associated with a failure to undergo apoptosis and increased endogenous IL-10 production. This study was undertaken to identify IL-10 effects in the NZB murine model of CLL.

Materials And Methods: Antisense IL-10 was employed in vitro and in vivo to decrease IL-10 protein. Following treatment, cells were analyzed for alterations in cell cycle and RNA was studied for alterations in gene expression. Additional in vivo studies employed NZB mice in which the IL-10 gene was deleted.

Results: IL-10 (-/-) knockout NZB mice overwhelmingly failed to develop leukemia. In vitro antisense IL-10 treatment resulted in a G2/M block and apoptosis and in vivo treatment with antisense IL-10 increased the survival of mice. Microarray analysis indicated a significant role for IL-10 in cell cycle regulation via cdc25C up-regulation and decreased p47 redox activity.

Conclusion: In summary, IL-10 is a critical survival factor for malignant B cells via anti-apoptotic and cell cycle effects.

Download full-text PDF

Source

Publication Analysis

Top Keywords

antisense il-10
12
cell cycle
12
il-10
10
nzb mice
8
analysis il-10
4
nzb
4
il-10 nzb
4
nzb leukemic
4
leukemic model
4
model background
4

Similar Publications

Background: The long non-coding RNA interferon gamma antisense-1 (IFNGAS-1) is essential for Th1 lineage specific expression of IFNG. IFN-γ is a key component cytokine in host immune response against intracellular pathogens like Leishmania. We investigated the association of two genetic variants of IFNGAS-1, rs4913269 and rs7134599, with susceptibility or protection to Leishmania guyanensis- induced cutaneous leishmaniasis (Lg-CL).

View Article and Find Full Text PDF

Background: The role of cardiac CD (cluster of differentiation) 206 macrophages in chronic heart failure (HF) is unknown. We examined whether CD206 macrophages expressing IL (interleukin)-4Rα are key drivers of adverse left ventricular (LV) remodeling in HF.

Methods: Adult C57BL/6 mice underwent nonreperfused myocardial infarction to induce HF.

View Article and Find Full Text PDF

This in vivo study explored the impact of TUBB6 inhibition in intracerebral hemorrhage (ICH), focusing on its effects on hematoma volume, microtubule stability, inflammation, neuronal preservation, and sensorimotor recovery. Sprague-Dawley rats was used to induce ICH by collagenase injection into the right striatum, followed by administration of TUBB6 antisense oligonucleotide (ASO) or Control ASO directly into the hematoma site 3 h post-ICH. Outcomes measured included hematoma volume, microtubule stability (acetylated α-tubulin), levels of inflammatory cytokines, mitogen-activated protein kinase (MAPK) pathway activity, neuronal degeneration (Fluoro-Jade C staining), and cell integrity (Cresyl Violet staining).

View Article and Find Full Text PDF

Mesoderm induction is a crucial step for vascular cell specification, vascular development and vasculogenesis. However, the cellular and molecular mechanisms underlying mesoderm induction remain elusive. In the present study, a chemically-defined differentiation protocol was used to induce mesoderm formation and generate functional vascular cells including smooth muscle cells (SMCs) and endothelial cells (ECs) from human induced pluripotent stem cells (hiPSCs).

View Article and Find Full Text PDF

Cytokines in cerebrospinal fluid as a prognostic predictor after treatment of nusinersen in SMA patients.

Clin Neurol Neurosurg

September 2024

Department of Geriatrics, the First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing, Jiangsu 210029, China. Electronic address:

Article Synopsis
  • - This study investigates the link between neuroinflammation and spinal muscular atrophy (SMA), focusing on how it impacts the effectiveness of nusinersen, a treatment for the condition.
  • - Researchers evaluated 15 SMA patients' motor functions and measured specific inflammatory biomarkers (MCP1, TNF-α, IL-10) in their cerebrospinal fluid before, during, and after 6 months of nusinersen treatment.
  • - Results showed increased MCP1 levels and decreased TNF-α over time, with IL-10 levels negatively impacting motor function scores, indicating that neuroinflammation might affect both SMA severity and treatment outcomes.
View Article and Find Full Text PDF